Swalqol in Primary Hyperparathyroidism

Uşak University150 enrolled

Overview

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Patients who will undergone parathyroidectomy for primary hyperparathyroidism will be included in the study. Swal-Qol and Sf-36 forms will be used for evaluation of quality of life before and 1 month after the surgery. The change in the quality of life and swallowing related quality of life will be evaluated.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Hyperparathyroidism

Interventions

parathyroidectomyPROCEDURE

routine parathyroidectomy will be done for the treatment of adenoma

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * no diagnosis of Alzheimers disease * must be able to swallow tablets Planned operation for primary hyperparathyroidism Exclusion Criteria: * secondary or tertiary hyperparathyroidism * insulin dependent diabetes * thyroid disease

Locations (1)

Uşak University

Uşak, Turkey (Türkiye)

Outcomes

Primary Outcomes

Change in quality of life

Quality of life will be evaluated using short form 36

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.